A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene
- PMID: 10053006
- PMCID: PMC1377789
- DOI: 10.1086/302275
A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene
Abstract
We have identified a novel fibroblast growth factor receptor 3 (FGFR3) missense mutation in four unrelated individuals with skeletal dysplasia that approaches the severity observed in thanatophoric dysplasia type I (TD1). However, three of the four individuals developed extensive areas of acanthosis nigricans beginning in early childhood, suffer from severe neurological impairments, and have survived past infancy without prolonged life-support measures. The FGFR3 mutation (A1949T: Lys650Met) occurs at the nucleotide adjacent to the TD type II (TD2) mutation (A1948G: Lys650Glu) and results in a different amino acid substitution at a highly conserved codon in the kinase domain activation loop. Transient transfection studies with FGFR3 mutant constructs show that the Lys650Met mutation causes a dramatic increase in constitutive receptor kinase activity, approximately three times greater than that observed with the Lys650Glu mutation. We refer to the phenotype caused by the Lys650Met mutation as "severe achondroplasia with developmental delay and acanthosis nigricans" (SADDAN) because it differs significantly from the phenotypes of other known FGFR3 mutations.
Similar articles
-
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3.Am J Med Genet. 1999 Jul 2;85(1):53-65. Am J Med Genet. 1999. PMID: 10377013
-
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.Am J Hum Genet. 2000 Dec;67(6):1411-21. doi: 10.1086/316892. Epub 2000 Oct 27. Am J Hum Genet. 2000. PMID: 11055896 Free PMC article.
-
Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.Hum Mol Genet. 2001 Jun 1;10(12):1255-64. doi: 10.1093/hmg/10.12.1255. Hum Mol Genet. 2001. PMID: 11406607
-
The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.Endocr Rev. 2000 Feb;21(1):23-39. doi: 10.1210/edrv.21.1.0387. Endocr Rev. 2000. PMID: 10696568 Review.
-
[From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].Ned Tijdschr Geneeskd. 2001 Jun 2;145(22):1056-9. Ned Tijdschr Geneeskd. 2001. PMID: 11414167 Review. Dutch.
Cited by
-
A case of long-term survival of SADDAN treated with growth hormone for marked short stature.Clin Pediatr Endocrinol. 2024;33(3):144-150. doi: 10.1297/cpe.2023-0068. Epub 2024 Mar 10. Clin Pediatr Endocrinol. 2024. PMID: 38993719 Free PMC article.
-
Clinical management and emerging therapies of FGFR3-related skeletal dysplasia in childhood.Ann Pediatr Endocrinol Metab. 2022 Jun;27(2):90-97. doi: 10.6065/apem.2244114.057. Epub 2022 Jun 30. Ann Pediatr Endocrinol Metab. 2022. PMID: 35793999 Free PMC article.
-
Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.Int J Mol Sci. 2021 Apr 21;22(9):4321. doi: 10.3390/ijms22094321. Int J Mol Sci. 2021. PMID: 33919228 Free PMC article. Review.
-
Fibroblast growth factor receptor signaling as therapeutic targets in female reproductive system cancers.J Cancer. 2020 Oct 21;11(24):7264-7275. doi: 10.7150/jca.44727. eCollection 2020. J Cancer. 2020. PMID: 33193890 Free PMC article. Review.
-
Enhanced FGFR3 activity in postmitotic principal neurons during brain development results in cortical dysplasia and axonal tract abnormality.Sci Rep. 2020 Oct 28;10(1):18508. doi: 10.1038/s41598-020-75537-0. Sci Rep. 2020. PMID: 33116259 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous